Meridian Bioscience reported $1.02M in Cash and Equivalent for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Abbott ABT:US $ 7675M 2124M
Accelerate Diagnostics AXDX:US 13.65M 26.24M
Atrion ATRI:US 32.26M 8.61M
Becton, Dickinson and BDX:US $ 3147M 1244M
Bio Rad Laboratories BIO:US $ 802.32M 331.53M
Cerulean Pharma CERU:US $ 39.32M 12.36M
Cerus CERS:US $ 38.37M 10.39M
Meridian Bioscience VIVO:US $ 1.02M 0M
Myriad Genetics MYGN:US $ 27.2M 231.2M
Orasure Technologies OSUR:US $ 70.72M 46.04M
Quidel QDEL:US $ 1275.54M 472.78M
Sientra SIEN:US $ 38.88M 12.89M
Staar Surgical STAA:US $ 193.07M 6.64M
Thermo Fisher Scientific TMO:US $ 2752M 1725M
Utah Medical Products UTMD:US $ 64.32M 8.29M